Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Radiology
•
Inflammatory arthritis
•
Nuclear Medicine
When would you consider utilizing bone scintigraphy in the assessment of inflammatory arthritis?
Answer from: at Community Practice
When it's a case of negative RA disease or when considering a neoplastic, gammopathy with myeloma...
Sign in or Register to read more
Answer from: at Community Practice
I would also consider using triple phase bone scan to assess the blood pool phase which may help determine sites of active inflammation. This may also help guide sites for intervention/injection.
Sign in or Register to read more
14606
22338
Related Questions
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Does the presence of calcified granulomas on chest imaging influence your choice of biologic for treatment of psoriatic arthritis (or rheumatoid arthritis)?
When considering a biologic for seropositive RA after failure of methotrexate or triple therapy, do you consider using abatacept as a first line biologic or would prefer choosing TNFi?
Do oral NSAIDs and steroids have an effect on how you interpret synovial fluid leukocyte count?
Do you combine methotrexate and leflunomide for the treatment of RA?
How do you approach medication management in patients with RA when transitioning from csDMARD triple therapy to anti-TNF?
What is your approach to differentiating and managing DMARD-induced nodulosis (induced by methotrexate or leflunomide for example) from "de novo" RA nodules in seropositive RA patients?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?